AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 36 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $11,000 | -15.4% | 2,211 | -11.3% | 0.00% | – |
Q4 2020 | $13,000 | +8.3% | 2,493 | 0.0% | 0.00% | – |
Q3 2020 | $12,000 | -25.0% | 2,493 | -23.4% | 0.00% | – |
Q2 2020 | $16,000 | +77.8% | 3,253 | +58.7% | 0.00% | – |
Q2 2019 | $9,000 | -35.7% | 2,050 | 0.0% | 0.00% | – |
Q1 2019 | $14,000 | +180.0% | 2,050 | +153.1% | 0.00% | – |
Q4 2018 | $5,000 | -64.3% | 810 | 0.0% | 0.00% | – |
Q3 2018 | $14,000 | – | 810 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bratton Capital Management, L.P. | 11,503,294 | $36,580,000 | 71.47% |
WEDBUSH SECURITIES INC | 98,489 | $313,000 | 0.03% |
Tower Research Capital LLC (TRC) | 29,536 | $94,000 | 0.01% |
OXFORD ASSET MANAGEMENT LLP | 72,296 | $230,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 114,211 | $363,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,000 | $191,000 | 0.00% |
Baker Brothers Advisors | 99,600 | $317,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 8,129 | $26,000 | 0.00% |
Squarepoint Ops LLC | 40,777 | $130,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 100,089 | $318,000 | 0.00% |